Shimadzu's Recent Advances in SFC
Supercritical Fluid Chromatography (SFC), a chromatographic technique using a supercritical CO2 mobile phase, has been known for decades but was seldom used due to the popularity of normal and reverse phase liquid chromatography.
Several years ago, SFC found a niche in chiral resolution when it was found that the physical characteristics of supercritical fluids can offer unique separations when compared to traditional liquid chromatography methods. Since then, these unique separations and “greener” aspect of CO2 have sparked new interest broadening SFC applications. Shimadzu, the leader in innovative SFC instrumentation, offers an array of analytical and preparative SFC systems that allow researchers easily access this growing technology. In this webinar, we’ll look at how Shimadzu’s SFC instruments and how our unique features are currently used in a variety of cutting edge applications for small and large molecules.
Presenter: Stephen Swartz (Business Development Specialist, Shimadzu Scientific Instruments)
Steve has been involved with the pharmaceutical industry for over 33 years. As a medicinal chemist at DuPont, Bayer, and Bristol Myers Squibb, he worked in multiple therapeutic areas supporting early phase discovery. After leaving the lab, Steve worked for several instrumentation companies in scientific support, sales, and business development. Since joining Shimadzu in 2020 as Business Development Specialist, he has worked with customers in the pharma and biopharma markets using his experience to help optimize workflows from early discovery to IND and beyond.
Presenter: Kevin Wons (Market Manager - Pharma/BioPharma, Shimadzu Scientific Instruments)
Kevin has recently joined Shimadzu as Market Manager for Pharma/BioPharma. He has spent the last 6 years at AstraZeneca in the Analytical Sciences Department for product and process characterization for biologics in the AstraZeneca pipeline. Kevin has applications experience with HPLC and LC-MS to do Tryptic Peptide Mapping, Intact Mass Analysis, Subunit Mass Analysis, and Oligosaccharide Profiling. For his last 3 years, he acted as the Glycan Subject Matter Expert (SME) while at AstraZeneca. His work experience also includes Maryland Psychiatric Research Center, where he prepared animal tissue samples such as Brain, Liver, Blood, and Placenta to measure kynurenine pathway metabolites on GC/MS and HPLC. He has a Master’s degree in Professional Studies (MPS) focused on Biotechnology which prepares science professionals to fill management and leadership roles.
